Table of Contents
Overview
New York, NY – May 23, 2025 – Global Veterinary Lasers Market was valued at USD 320.5 million in 2024 and is anticipated to register substantial growth of USD 724.6 million by 2034, with 8.5% CAGR. In 2023
The global veterinary laser market is witnessing sustained growth, driven by increasing pet adoption, heightened awareness of animal welfare, and the rising prevalence of chronic and post-operative conditions in companion animals. Veterinary lasers non-invasive tools that utilize light to stimulate cell regeneration and reduce inflammation are becoming essential in modern veterinary practices.
These systems are being widely adopted for pain management, wound healing, arthritis, musculoskeletal disorders, and post-surgical recovery in pets, horses, and exotic animals. Therapeutic laser technology offers a drug-free alternative to traditional treatments, improving mobility and enhancing quality of life with minimal side effects. Clinics are increasingly integrating Class III and Class IV laser systems into rehabilitation and surgical protocols to provide comprehensive care.
North America leads the market, supported by high veterinary care expenditure and early adoption of advanced modalities. However, rapid growth is being observed in Asia-Pacific due to rising disposable incomes and improved veterinary infrastructure. Technological advancements, such as portable units and preset therapy protocols, are further contributing to adoption among small to mid-sized veterinary practices. As the veterinary healthcare industry continues to evolve, laser therapy is positioned as a vital tool in preventive and therapeutic animal care. Continued investments in research and clinical validation are expected to further expand its application and market penetration globally.
Key Takeaways
- In 2024, the global veterinary lasers market was valued at USD 320.5 million and is projected to grow significantly, reaching approximately USD 724.6 million by 2034, expanding at a compound annual growth rate (CAGR) of 8.5%.
- The dogs segment emerged as the leading animal type in 2024, accounting for 47% of the global market revenue, reflecting the high demand for laser therapy among canine patients.
- Veterinary hospitals and clinics dominated the end-user segment in 2024, capturing 56% of the total revenue share, driven by the widespread adoption of laser technology in clinical veterinary practices.
- North America continued to lead the global veterinary lasers market in 2024, holding a dominant share of over 37% of the total revenue, supported by advanced veterinary infrastructure and high pet care expenditure.
Segmentation Analysis
- By Animal Type: The global veterinary lasers market is segmented into dogs, cats, and others, with dogs dominating at 47% market share in 2024. This dominance is attributed to the growing incidence of chronic conditions such as arthritis, hip dysplasia, and obesity among dogs. As dogs are increasingly treated as family members, the demand for advanced, non-invasive therapies like laser treatment is rising. These treatments aid in pain relief, improve mobility, and support recovery, particularly in aging and overweight pets.
- By End Use: In 2024, veterinary hospitals and clinics held the largest share of the global veterinary lasers market at 56%. This leadership is driven by the widespread integration of laser technologies in clinical procedures for both therapeutic and surgical applications. Hospitals utilize lasers extensively for pain relief, wound healing, and soft tissue surgeries. The increasing focus on advanced, non-invasive treatments and the expansion of specialized veterinary facilities continue to boost demand for laser systems in clinical environments.
- By Application: The pain and inflammation management segment led the veterinary lasers market in 2024, accounting for 32% of the total share. This growth is fueled by the rising need for drug-free, non-invasive solutions to treat chronic pain in pets. Laser therapy is frequently used to manage conditions like arthritis, post-operative inflammation, and musculoskeletal injuries. By enhancing cellular repair and circulation, laser treatments offer effective, side-effect-free alternatives to traditional medication, thus gaining widespread acceptance in veterinary practices globally.
Market Segments
By Animal
- Dogs
- Cats
- Others
By End Use
- Veterinary Hospitals & Clinics
- Others
By Application
- Pain & Inflammation Management
- Regeneration/Tissue Repair
- Others
Regional Analysis
North America accounted for approximately 37% of the global veterinary lasers market in 2024, underscoring its leadership in advanced animal healthcare. This dominance is supported by high pet ownership rates, substantial expenditure on pet wellness, and the rapid integration of innovative, non-invasive treatments across veterinary practices.
The United States is the primary driver within the region, with a vast network of veterinary clinics increasingly utilizing laser therapy for managing pain, inflammation, and musculoskeletal conditions in pets. Growing awareness among pet owners regarding the therapeutic benefits of laser treatments continues to fuel market demand.
According to the American Pet Products Association, U.S. pet owners spent approximately USD 147.0 billion on companion animals in 2023, with USD 38.3 billion directed toward veterinary care and related products, further reinforcing the market’s robust growth trajectory in North America.
Emerging Trends
- Regulatory Facilitation and Market Entry: Veterinary lasers have been classified by the U.S. Food and Drug Administration (FDA) under product code RGB and are exempt from Good Manufacturing Practice (GMP) requirements, except for basic record-keeping and complaint handling (21 CFR 820.180, 820.198). This exemption status has reduced barriers to market entry and encouraged a wider range of manufacturers to develop devices for animal treatment.
- Expansion of Photobiomodulation Research: The application of low-level laser therapy (LLLT), also known as photobiomodulation, has been increasingly studied in veterinary settings. A systematic literature review covering 1980–2020 identified 45 peer-reviewed articles on light therapy in animals: 24 focused on dogs, 1 on cats, and the remainder on horses. Indications ranged from musculoskeletal and neurologic conditions to skin diseases and wound healing.
- Broadened Clinical Indications: Beyond traditional use for pain relief and soft-tissue healing, veterinary lasers are now being applied in dermatologic procedures (e.g., CO laser ablation of lesions), neurological rehabilitation, and even dental surgery. For instance, CO laser modalities have become common in treating dermatologic conditions such as tumor removal and chronic otitis, while dental lasers are used to provide bloodless surgical fields in periodontal therapy.
- Growth of Non-Thermal Adjunct Devices: A new class of non-thermal, light-based instruments has emerged for adjunctive pain therapy. In 2022, the Erchonia GVL device (510(k) K221987) received FDA clearance as a “Powered Light Based Laser Non-Thermal Instrument With Non-Heating Effect for Adjunctive Use in Pain Therapy,” reflecting a trend toward safer, non-invasive modalities in veterinary practice.
- Increasing Clinical Evidence: Recent clinical studies have demonstrated tangible benefits of laser therapy in animals. For example, a 2022 trial showed that dogs with osteoarthritis experienced measurable increases in activity levels following LLLT, indicating improved mobility and quality of life. Moreover, photobiomodulation research published in 2023 noted a growing body of evidence supporting laser use in rehabilitation, sports medicine, and general veterinary practice.
Use Cases
- Musculoskeletal Pain and Osteoarthritis: LLLT is used to reduce inflammation and relieve pain in conditions such as hip dysplasia and osteoarthritis. In one study, dogs treated with LLLT exhibited significant increases in daily activity counts, as measured by accelerometers, demonstrating enhanced mobility.
- Wound Healing and Infection Control: Photobiomodulation has been applied to contaminated wounds in dogs, where it was found to decrease bacterial loads and improve wound-healing scores. Such protocols are increasingly adopted in post-surgical care to reduce infection risk and accelerate tissue repair.
- Dermatologic Surgery: CO₂ lasers are employed for precise removal of skin tumors and treatment of chronic skin conditions. The modality allows for controlled ablation with minimal bleeding, reducing procedure time and post-operative complications.
- Neurological Rehabilitation: Laser therapy is utilized in the management of neurological disorders, including peripheral nerve injuries and neuropathic pain. Clinical protocols often involve near-infrared wavelengths that penetrate deep tissue layers to modulate nerve function and promote regeneration.
- Dental Procedures: In veterinary dentistry, lasers facilitate access to hard-to-reach areas and provide hemostasis during periodontal surgery. Their bactericidal properties also help in reducing microbial load in the oral cavity, improving treatment outcomes.
- Preventive and Performance Medicine: Photobiomodulation is increasingly adopted by sports-medicine veterinarians to support muscle recovery and reduce downtime in performance animals. Treatment regimens are tailored by wavelength and dose to optimize tissue repair and athletic performance.
Conclusion
The global veterinary lasers market is positioned for sustained expansion, driven by rising pet ownership, increased demand for non-invasive treatments, and growing clinical evidence supporting laser therapy efficacy. With strong market performance in 2024 and a projected value of USD 724.6 million by 2034, the sector is benefiting from technological innovation, broadened clinical applications, and supportive regulatory environments.
North America remains the dominant region, while Asia-Pacific shows rapid growth potential. As veterinary practices prioritize preventive care and rehabilitation, laser therapy is becoming an essential component in enhancing animal health outcomes and advancing the standard of care in veterinary medicine.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
